Merck & Co., Inc. (NYSE:MRK) will look for acquisition opportunities. Merck announced that it continues to strengthen the portfolio through strategic acquisitions and are prioritizing the development of several promising oncology candidates with the potential to improve the treatment of advanced cancers.